newsfilter
← Latest News
GlobeNewswire·

eFFECTOR Therapeutics to Host Virtual Investor R&D Day on January 24, 2024

- Summary of development progress for tomivosertib and zotatifin and a preview of anticipated 2024 milestones- - Review of recently announced interim data from dose escalation and Phase 2 expansion cohorts of